(Q34543588)

2 August 2017

Enalapril dosage in steroid-resistant nephrotic syndrome (English)

1 reference

2 August 2017

1 reference

Arvind Bagga

1

1 reference

2 August 2017

Basanagoud D Mudigoudar

series ordinal

2

1 reference

2 August 2017

Pankaj Hari

series ordinal

3

1 reference

2 August 2017

Vandita Vasudev

series ordinal

4

1 reference

2 August 2017

25 November 2003

1 reference

2 August 2017

1 reference

2 August 2017

19

1 reference

2 August 2017

1

1 reference

2 August 2017

45-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1314-y

2 August 2017

0 references

cites work

Enalapril and prednisone in children with nephrotic-range proteinuria

1 reference

12 December 2020

Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies

1 reference

12 December 2020

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

12 December 2020

Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

1 reference

12 December 2020

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome

1 reference

12 December 2020

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

12 December 2020

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease

1 reference

12 December 2020

Enalapril: antiproteinuric effect in children with nephrotic syndrome

1 reference

12 December 2020

Cholesterol: a renal risk factor in diabetic nephropathy?

1 reference

12 December 2020

ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome

1 reference

12 December 2020

Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis.

1 reference

12 December 2020

Long-term therapy with enalapril in patients with nephrotic-range proteinuria

1 reference

12 December 2020

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

1 reference

12 December 2020

Consensus statement on management of steroid sensitive nephrotic syndrome.

1 reference

12 December 2020

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

1 reference

12 December 2020

Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy

1 reference

12 December 2020

Renal damage associated with proteinuria

1 reference

12 December 2020

Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function

1 reference

12 December 2020

10.1007/S00467-003-1314-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference